![]() |
Volumn 294, Issue 5547, 2001, Pages 1638-1642
|
Gene therapy: Safer and virus-free?
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DNA VACCINE;
OLIGONUCLEOTIDE;
PLASMID DNA;
VIRUS VECTOR;
GENE;
VIRUS;
ADENOVIRUS;
CHIMERAPLASTY;
CLINICAL TRIAL;
DNA VECTOR;
ELECTROPORATION;
GENE CONSTRUCT;
GENE TARGETING;
GENE THERAPY;
GENE TRANSFER;
GENETIC ENGINEERING;
HUMAN;
NONHUMAN;
PRIORITY JOURNAL;
RETROVIRUS;
REVIEW;
RISK ASSESSMENT;
ANIMALS;
BIOLISTICS;
BLOOD PRESSURE;
CLINICAL TRIALS;
CORONARY ARTERIOSCLEROSIS;
DNA;
ELECTROPORATION;
GENE EXPRESSION;
GENE THERAPY;
GENE TRANSFER TECHNIQUES;
GENETIC VECTORS;
HEMOPHILIA A;
HUMANS;
INJECTIONS, INTRA-ARTERIAL;
MELANOMA;
MICROINJECTIONS;
MUSCULAR DYSTROPHIES;
ORGAN SPECIFICITY;
PLASMIDS;
RNA;
TIME FACTORS;
TRANSFECTION;
TRANSGENES;
VIRUSES;
ADENOVIRIDAE;
UNIDENTIFIED RETROVIRUS;
|
EID: 0035941087
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.294.5547.1638 Document Type: Review |
Times cited : (290)
|
References (0)
|